TRUST METID From black-box Data to TRUSTworthy LC-MS METabolomics IDentifications
- Coordinator
- Aristotelio Panepistimio Thessalonikis, Greece
- Runs
- 1 January 2027 to 31 December 2030
- Status
- Running
- EU funding
- €641k
- Total cost
- —
- Partners
- 11 organisations in 6 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101345004
What the project is doing
In the project's own words, from its summary on CORDIS.
Metabolomics is growing rapidly, surpassing 15,000 publications annually. Untargeted LC-MS, the dominant analytical technique, generates thousands of molecular features per experiment, but only a small fraction can be confidently identified, mapped to biochemical pathways, and translated into meaningful biological insight. Limitations in analytical reproducibility and in the coverage and usability of mass spectral libraries lead to misannotations and poor pathway integration, creating significant scientific and economic inefficiencies and hindering the broader adoption of metabolomics in clinical and industrial settings.
TRUST METID project addresses this systemic challenge by integrating advances across three critical domains: signal generation and utilization, computational work towards metabolite identification, and pathway mapping. The project combines investigations on analyte detection in LC-MS with the development of artefact-resistant data processing workflows, improved annotation confidence scoring systems, and robust strategies for biochemical validation and pathway integration.
Through a structured programme of 124 months of international/intersectoral secondments, TRUST METID project brings together academia, industry, and data infrastructure partners to enable knowledge exchange. Researchers will co-develop standards, interoperable tools, and workflows, while contributing to training materials, tutorials, protocols, and community guidelines. Via international industry-academia collaboration, TRUST METID will contribute in transforming LC-MS metabolomics metabolite identification from a largely fragmented workflow into a mechanistically grounded, reproducible analytical framework, to significantly increase identification confidence, reduce false discoveries, and enhance biological interpretability.
The project will deliver lasting impact through open resources, improved databases supporting the reliable translation of metabolomics into real-world applications.
Topics
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| Aristotelio Panepistimio Thessalonikis | Thessaloniki | Greece | Coordinator |
| European Molecular Biology Laboratory | Heidelberg | Germany | Associatedpartner |
| Ecole Nationale Veterinaire De Toulouse | Toulouse | France | Associatedpartner |
| Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement | Paris | France | Participant |
| Purpan | Toulouse | France | Associatedpartner |
| Universite De Toulouse | Toulouse | France | Associatedpartner |
| Wageningen University | Wageningen | Netherlands | Participant |
| Imperial College of Science Technology and Medicine | London | United Kingdom | Participant |
| Micromass UK Ltd | Wilmslow Cheshire | United Kingdom | Associatedpartner |
| The University of Liverpool | Liverpool | United Kingdom | Participant |
| The Regents of the University of California | Oakland | United States | Associatedpartner |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI